DeutschNewstral
Article
New York Post on 2021-05-04 17:40
Pfizer expects $26 billion in 2021 sales from COVID vaccine
Related news
- BPfizer Expects $26B in Covid-19 Vaccine Sales This Yearbarrons.com
Pfizer sees COVID-19 vaccine, therapeutic sales topping $50 billion in 2022timesofisrael.com
Pfizer expects Covid vaccine demand for yearsBBC- Pfizer CEO expects 3rd dose of vaccine will be necessary within a yeartimesofisrael.com
- Pfizer expects $15bn sales of Covid-19 vaccineBBC
[Ticker] Pfizer expects €22bn in vaccine sales this yeareuobserver.com
Vaccine sales power Pfizer through first quarterSeattle Times
Pfizer expects $20b in COVID-19 vaccine revenue this yearSydney Morning Herald
Pfizer predicts: We'll rake in $$ 33.5 billion in vaccine salesisraelnationalnews.com- TPfizer posts narrower Q3 loss amid slumping Covid vaccine salesthestreet.com
- Pfizer hikes 2021 outlook after vaccine boosts sales, profittimesofisrael.com
Pfizer records $22bn COVID-19 vaccine sales in 2021punchng.com- Pfizer’s COVID sales forecast wipes $21 billion off vaccine stocksSydney Morning Herald
- FPfizer halts China vaccine salesft.com
Pfizer Launches $3.5 Billion Cost-Cutting Program Amid Declining Covid Vaccine SalesForbes- Pfizer Triggers $28 Billion Stock Plunge After Warning Covid Vaccine Sales May Disappoint This YearForbes
Pfizer coronavirus vaccine revenue projected to hit $26 billion in 2021 with production surgepost-gazette.com- BBusinessinsider.co.za | Pfizer CEO expects to deliver 2 billion vaccines on time, and is 'encouraged' by SA variant studybusinessinsider.com
EU agrees to potential 1.8 billion-dose purchase of Pfizer vaccineThe Day